Atlas Trials

Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications

Clinical trial NCT05321641 · UNKNOWN

Trial details

NCT number
NCT05321641
Sponsor
KEMRI-Wellcome Trust Collaborative Research Program
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
EpilepsyTreatment Adherence
Start date
2022-05-01
Primary completion
2024-05-01
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.